ATE440153T1 - Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie - Google Patents

Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie

Info

Publication number
ATE440153T1
ATE440153T1 AT04799655T AT04799655T ATE440153T1 AT E440153 T1 ATE440153 T1 AT E440153T1 AT 04799655 T AT04799655 T AT 04799655T AT 04799655 T AT04799655 T AT 04799655T AT E440153 T1 ATE440153 T1 AT E440153T1
Authority
AT
Austria
Prior art keywords
ims
seq
kit
assessing
adverse effects
Prior art date
Application number
AT04799655T
Other languages
English (en)
Inventor
Yoshio Miki
Masaaki Matsuura
Minoru Isomura
Satoshi Miyata
Masataka Yoshimoto
Tetsuo Noda
Original Assignee
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Found Cancer filed Critical Japan Found Cancer
Application granted granted Critical
Publication of ATE440153T1 publication Critical patent/ATE440153T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT04799655T 2003-11-05 2004-11-05 Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie ATE440153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003375369 2003-11-05
PCT/JP2004/016805 WO2005045029A1 (ja) 2003-11-05 2004-11-05 パクリタキセル療法による副作用を予測する方法およびキット

Publications (1)

Publication Number Publication Date
ATE440153T1 true ATE440153T1 (de) 2009-09-15

Family

ID=34567070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04799655T ATE440153T1 (de) 2003-11-05 2004-11-05 Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie

Country Status (8)

Country Link
US (1) US20070238098A1 (de)
EP (1) EP1688492B1 (de)
JP (1) JP4549297B2 (de)
KR (1) KR20070003777A (de)
CN (1) CN1871349B (de)
AT (1) ATE440153T1 (de)
DE (1) DE602004022702D1 (de)
WO (1) WO2005045029A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050260603A1 (en) 2002-12-31 2005-11-24 Mmi Genomics, Inc. Compositions for inferring bovine traits

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528260B1 (en) * 1999-03-25 2003-03-04 Genset, S.A. Biallelic markers related to genes involved in drug metabolism
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
AU2002344369A1 (en) * 2001-06-01 2002-12-16 Epidauros Biotechnologie Ag Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
JP2003093068A (ja) * 2001-09-25 2003-04-02 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho 代謝酵素ｃｙｐ２ｃ８の多型を利用した、薬物代謝の検査方法および検査薬並びに薬物代謝を改善する化合物のスクリーニング方法
AU2002360452A1 (en) * 2001-11-28 2003-06-10 Dnaprint Genomics, Inc. Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness

Also Published As

Publication number Publication date
JPWO2005045029A1 (ja) 2007-05-17
KR20070003777A (ko) 2007-01-05
CN1871349B (zh) 2011-04-06
US20070238098A1 (en) 2007-10-11
DE602004022702D1 (de) 2009-10-01
CN1871349A (zh) 2006-11-29
JP4549297B2 (ja) 2010-09-22
EP1688492A1 (de) 2006-08-09
EP1688492A4 (de) 2006-12-20
EP1688492B1 (de) 2009-08-19
WO2005045029A1 (ja) 2005-05-19

Similar Documents

Publication Publication Date Title
DK1159453T3 (da) Fremgangsmåde til direkte nukleinsyresekventering
NO986133D0 (no) FremgangsmÕte for DNA-sekvensering
GB2373500A (en) Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
ATE421991T1 (de) Stammzellen und verfahren zu deren trennung
ATE348881T1 (de) Thermostabiles taq polymerase fragment
WO2005080594A3 (en) Method for determining the risk of developing a neurological disease
ATE469162T1 (de) Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c
ATE440153T1 (de) Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie
DE60327048D1 (de) Verfahren zur in vivo quantifizierung von nukleinsäuren
WO2003064600A3 (en) The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
WO2003060160A3 (en) Verification of fish origin based on nucleic acid pattern recognition
DE60324819D1 (de) Verfahren zur amplifikation von nukleinsäure, kit zur amplifikation von nukleinsäure, verfahren zum nachweis von einzelnukleotid-polymorphismus und reagentienkit zum nachweis von einzelnukleotid-polymorphismus
ATE544852T1 (de) Verfahren zur beurteilung der gefahr arzneimittelinduzierter granulozytopenie
WO2004063324A3 (en) Canine gene microarrays
DE60212930D1 (de) Detektionsmethode für Zielmoleküle, Reagenz sowie Verfahren zur Detektion von SNPs in DNA Nukleotidsequenzen
ATE488603T1 (de) Suszeptibilitätsgen für die alzheimersche krankheit
DE60212861D1 (de) Verfahren zur Diagnose von Fettsucht
DE602004014135D1 (de) Verfahren und zusammensetzungen zur vorhersage der irinotecantoxizität
WO2000056922A3 (en) Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof
HUP0203080A2 (hu) A PRV-1 gén és felhasználása
DE60311330D1 (de) Genetisches Verfahren zur Vorhersage des Glaukomarisikos
WO2005007816A3 (en) Compositions and methods for identifying an individual organism based on single nucleotide polymorphisms
ATE529532T1 (de) Genotyp spezifischer detektion von chlamydophila psittaci
ATE435924T1 (de) Verfahren zur identifizierung der milchproduktionsqualitäten in tieren durch analyse der pit-1 und kappa-kasein genpolymorphismus
ATE401426T1 (de) Verfahren zur identifizierung biologischer spezies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties